Skip to main content
OpenTrials

Clinical trial condition

Non-small Cell Lung Cancer

Explore clinical trials studying Non-small Cell Lung Cancer. Study availability and eligibility vary by location and protocol.

1,335 public trials 329 recruiting studies
Refine in advanced search Browse all conditions

Non-small Cell Lung Cancer trial results

Recruiting

Study to Assess Adverse Events and Pharmacokinetics in Adult Participants With Non-Small Cell Lung Cancer, Head and Neck Squamous Cell Carcinoma and Other Solid Tumors, Receiving Intravenous Infusion of Azirkitug Alone or in Combination(s) With Budigalimab, Bevacizumab, or Telisotuzumab Adizutecan

NCT05005403

Conditions
Anophthalmia with pulmonary hypoplasia, Breast Diseases, Breast Neoplasms, +38 more
Locations
  • City of Hope National Medical Center /ID# 276272 Duarte, California, United States
  • City of Hope - Orange County Lennar Foundation Cancer Center /ID# 278589 Irvine, California, United States
  • USC Norris Comprehensive Cancer Center /ID# 279603 Los Angeles, California, United States
  • University of Illinois Hospital and Health Sciences System /ID# 251750 Chicago, Illinois, United States
View all 48 locations
View Trial Details
Recruiting

Study of Izalontamab Brengitecan (BMS-986507) Versus Platinum-Pemetrexed for EGFR-mutated Non-small Cell Lung Cancer After Failure of EGFR TKI Therapy (IZABRIGHT-Lung01)

NCT07100080

Conditions
Bronchial Neoplasms, Carcinoma, Bronchogenic, Carcinoma, Non-Small-Cell Lung, +8 more
Locations
  • UCI Health - Chao Family Comprehensive Cancer Center and Ambulatory Care building Irvine, California, United States
  • University of California, Irvine (UCI) Health - UC Irvine Medical Center Orange, California, United States
  • Shaw Cancer Center Edwards, Colorado, United States
  • Local Institution - 0085 Gainesville, Florida, United States
View all 186 locations
View Trial Details
Recruiting

MOONRAY-01, A Study of LY3962673 in Participants With KRAS G12D-Mutant Solid Tumors

NCT06586515

Conditions
Bronchial Neoplasms, Carcinoma, Bronchogenic, Carcinoma, Non-Small-Cell Lung, +19 more
Locations
  • City of Hope Duarte, California, United States
  • University of California, Los Angeles (UCLA) Santa Monica, California, United States
  • Sarah Cannon Research Institute at HealthOne Denver, Colorado, United States
  • Sibley Memorial Hospital Washington D.C., District of Columbia, United States
View all 52 locations
View Trial Details
Recruiting

A Phase 2 Clinical Study of Combination Therapy With ABSK043 and Glecirasib

NCT07164170

Conditions
Bronchial Neoplasms, Carcinoma, Bronchogenic, Carcinoma, Non-Small-Cell Lung, +8 more
Locations
  • The First Affiliated Hospital of Anhui Medical University Hefei, Anhui, China
  • Beijing Cancer Hospital Beijing, Beijing Municipality, China
  • Cancer Hospital Chinese Academy of Medical Sciences Beijing, Beijing Municipality, China
  • Fujian Cancer Hospital Fuzhou, Fujian, China
View all 17 locations
View Trial Details
Recruiting

Phase 1/2 Trial of S241656 in Selected RAS/MAPK Mutation- Positive Malignancies

NCT05786924

Conditions
Acquired Resistance to KRAS G12C Inhibitor, BRAF, BRAF Gene Mutation, +61 more
Locations
  • Banner Health- MD Anderson Cancer Center Gilbert, Arizona, United States
  • The Angeles clinic - A cedars SINAI AFFILIATE Los Angeles, California, United States
  • USC Norris Comprehensive Cancer Center Los Angeles, California, United States
  • University of California, San Francisco (UCSF) San Francisco, California, United States
View all 27 locations
View Trial Details
Recruiting

Dose-Deescalated 3-Fraction Stereotactic Body Radiotherapy For Centrally Located Lung Cancer

NCT04210492

Conditions
Bronchial Neoplasms, Carcinoma, Bronchogenic, Carcinoma, Non-Small-Cell Lung, +8 more
Locations
  • Smilow Cancer Hospital Care Center at Greenwich Greenwich, Connecticut, United States
  • Smilow Cancer Hospital Care Center - Guilford Guilford, Connecticut, United States
  • Smilow Cancer Hospital - Hamden Care Center Hamden, Connecticut, United States
  • Smilow Cancer Hospital New Haven, Connecticut, United States
View Trial Details
Recruiting

Phase I Study of [177Lu]Lu-DFC413 in Patients With Solid Tumors

NCT07261631

Conditions
Breast Diseases, Breast Neoplasms, Bronchial Neoplasms, +30 more
Locations
  • Novartis Investigative Site Montreal, Quebec, Canada
  • Novartis Investigative Site Odense C, Denmark
  • Novartis Investigative Site Vandœuvre-lès-Nancy, France
  • Novartis Investigative Site Essen, Germany
View Trial Details

Related conditions